Technology News and Research

RSS

Applied BioCode receives U.S. patent for ‘Light Transmitted Assay Beads’

Applied BioCode, Inc. today announced that the United Stated Patent and Trademark Office has granted US Patent #8,232,092 "Light Transmitted Assay Beads," describing the method of decoding barcodes and analyzing bioassays using Barcoded Magnetic Beads (BMB) multiplex products.

7 Aug 2012

New Cornell study: Eyes reveal sexual orientation

There is a popular belief that sexual orientation can be revealed by pupil dilation to attractive people, yet until now there was no scientific evidence. For the first time, researchers at Cornell University used a specialized infrared lens to measure pupillary changes to participants watching erotic videos. Pupils were highly telling: they widened most to videos of people who participants found attractive, thereby revealing where they were on the sexual spectrum from heterosexual to homosexual.

7 Aug 2012

ICSSR launches first set of projects for networking and social science research

The Indian Council of Social Science Research (ICSSR) in association with the Deutsche For-schungsgemeinschaft (DFG, German Research Foundation), the French Agence Nationale de la Recherche (ANR), the UKEconomic and Social Research Council (ESRC), the Netherlands Organi-sation for Scientific Research (NWO) have launched the first set of projects for networking and social science research cooperation between researchers in India and the four European countries.

7 Aug 2012

UV dosimeter technology helps prevent over-exposure to the sun

A monitor developed at the University of Strathclyde in Glasgow, Scotland, to help prevent over-exposure to the sun is set to go on the market as part of a new spinout company.

7 Aug 2012

Early CT ‘definitive’ for subarachnoid hemorrhage diagnosis

Cerebrospinal fluid analysis is only necessary for patients with thunderclap headache and a negative computed tomography scan if they undergo imaging more than 6 hours after headache onset, research suggests.

6 Aug 2012

Wellcome Trust grants £1.6 million Translation Award for development of more effective radiotherapy

The Wellcome Trust has awarded a £1.6 million Translation Award to a research team led by the University of Lincoln to develop more effective radiotherapy treatment for thousands of cancer sufferers by providing unique monitoring and imaging for patients receiving proton therapy.

6 Aug 2012

FDA grants 510(k) clearance to VICTUS Femtosecond Laser Platform

Bausch + Lomb, the global eye health company, and Technolas Perfect Vision GmbH, a leading ophthalmology laser company, announced today that the VICTUS Femtosecond Laser Platform received 510(k) clearance from the U.S. Food and Drug Administration.

6 Aug 2012

New research center to expedite study of gene transfer approach

In an alliance aimed at bringing a new, personalized immunotherapy approach to patients with a wide variety of cancers, the University of Pennsylvania and Novartis announced today an exclusive global research and licensing agreement to further study and commercialize novel cellular immunotherapies using chimeric antigen receptor (CAR) technologies.

6 Aug 2012

Medical devices for diabetic peripheral neuropathy: an interview with Dr. Shai Gozani, CEO of NeuroMetrix

About two years ago NeuroMetrix changed their focus from general purpose devices, used to perform nerve conduction tests, to devices designed to specifically address diabetic peripheral neuropathy or DPN.

6 Aug 2012

Eliza receives U.S. patent allowance for Complex Acoustic Resonance Speech Analysis System

Eliza Corporation, the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System.

6 Aug 2012

Genocea announces new data that supports novel approach for development of HSV-2 vaccine

Genocea Biosciences announced today the presentation of new data supporting its novel approach to developing a first-in-class, protein subunit therapeutic vaccine for Herpes Simplex Virus type 2 (HSV-2).

6 Aug 2012

Montefiore launches first fellowship program in Women's Physical Medicine and Rehabilitation

Montefiore Medical Center has launched the nation's first fellowship program in Women's Physical Medicine and Rehabilitation (WPM&R), and established a new clinical program in this specialty.

6 Aug 2012

Public Health Wales uses Luminex's xTAG GPP for outbreak investigations during Olympic events

Luminex Corporation announced today that Public Health Wales is using Luminex's CE marked xTAG Gastrointestinal Pathogen Panel (GPP) for outbreak investigation activities during Olympic and Paralympic training and events taking place in Wales. Results of a substantial diagnostic validation of the GPP test conducted by The Public Health Wales Microbiology laboratory team at the University Hospital of Wales, Cardiff, are anticipated to be published in a peer reviewed journal

From Luminex 6 Aug 2012

Novartis, Penn partner to study and commercialize novel cellular immunotherapies for cancer

6 Aug 2012

Similar molecular pathways involved in intellectual disability due to Fragile X and Down syndromes

Intellectual disability due to Fragile X and Down syndromes involves similar molecular pathways report researchers in The EMBO Journal. The two disorders share disturbances in the molecular events that regulate the way nerve cells develop dendritic spines, the small extensions found on the surface of nerve cells that are crucial for communication in the brain.

3 Aug 2012

Viewpoints: Romney's 'repeal and replace' pledge; 'Socialized medicine' in the U.S.; Pros and cons of expanding Medicaid

Greg Sargent already took a crack at Mitt Romney's new "Plan for a Stronger Middle Class," but one thing that he didn't get to shouldn't be ignored: Romney is apparently still campaigning on a "repeal and replace" plan on health care reform.

3 Aug 2012

Power outage points out how technology can undermine patient care

Dozens of hospitals across the country lost access to crucial electronic medical records for about five hours during a major computer outage last week, raising fresh concerns about whether poorly designed technology can compromise patient care.

3 Aug 2012

Potential new drug to treat common inherited kidney disease

Scientists at UC Santa Barbara have demonstrated in the laboratory that a new drug is effective in treating a very common kidney disease -- although it will be a few years before it becomes available for clinical testing. The findings resulted from a collaboration between UCSB and a biotech firm based in Indiana. The study is published in this week's Journal of the American Society of Nephrology.

3 Aug 2012

Widespread use of current technologies 'essential' to improve global health

Noting that this week's issue of the Lancet explores the theme of "[a]ccess to beneficial health technology, including essential medicines and medical devices, for those most in need," a Lancet editorial states, "Maximizing use of current health technologies (drugs, devices, biological products, medical and surgical procedures, support systems, and organizational systems) is essential to improving global health."

3 Aug 2012

Gilead Sciences signs deals with 3 Indian pharmaceutical companies to promote low-cost HIV drugs in developing countries

Gilead Sciences Inc. announced Thursday that it plans to partner with Mylan Inc., Ranbaxy Laboratories Ltd. and Strides Arcolab Ltd. "to promote access to high-quality, low-cost generic versions of Gilead's HIV medicine emtricitabine in developing countries," the Wall Street Journal reports.

3 Aug 2012

Technology News and Research

Applied BioCode receives U.S. patent for ‘Light Transmitted Assay Beads’

New Cornell study: Eyes reveal sexual orientation

ICSSR launches first set of projects for networking and social science research

UV dosimeter technology helps prevent over-exposure to the sun

Early CT ‘definitive’ for subarachnoid hemorrhage diagnosis

Wellcome Trust grants £1.6 million Translation Award for development of more effective radiotherapy

FDA grants 510(k) clearance to VICTUS Femtosecond Laser Platform

New research center to expedite study of gene transfer approach

Medical devices for diabetic peripheral neuropathy: an interview with Dr. Shai Gozani, CEO of NeuroMetrix

Eliza receives U.S. patent allowance for Complex Acoustic Resonance Speech Analysis System

Genocea announces new data that supports novel approach for development of HSV-2 vaccine

Montefiore launches first fellowship program in Women's Physical Medicine and Rehabilitation

Public Health Wales uses Luminex's xTAG GPP for outbreak investigations during Olympic events

Novartis, Penn partner to study and commercialize novel cellular immunotherapies for cancer

Similar molecular pathways involved in intellectual disability due to Fragile X and Down syndromes

Viewpoints: Romney's 'repeal and replace' pledge; 'Socialized medicine' in the U.S.; Pros and cons of expanding Medicaid

Power outage points out how technology can undermine patient care

Potential new drug to treat common inherited kidney disease

Widespread use of current technologies 'essential' to improve global health

Gilead Sciences signs deals with 3 Indian pharmaceutical companies to promote low-cost HIV drugs in developing countries

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News